Anthea Peters

17PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 05, 2026
Dual action of pimozide through lysosome disruption and inhibition of STATs induces apoptosis in chronic lymphocytic leukemia (CLL).

|Jan 21, 2026
Fibrin-Associated Large B-Cell Lymphoma of Prosthetic Aortic Valve and Aortic Root Graft.

Ashish Rajput, Abdulrahim Alabdulsalam, Claribeth Ruano

|Dec 26, 2025
Real-world eligibility, utilization, and barriers to CAR T-cell therapy in relapsed/refractory mantle cell lymphoma.

Robert Puckrin, Vladimir Sapon-Cousineau, Anthea Peters

|Oct 06, 2025
Management of Canadian patients with refractory or relapsed diffuse large B-cell lymphoma in the real world: a subanalysis of the RE-MIND2 study.

Anthea Peters, Grzegorz S Nowakowski, Rosy Dabas

|Mar 21, 2025
Evaluating the impact of a pharmacist-led venetoclax ramp-up clinic for chronic lymphocytic leukemia patients: A retrospective chart review.

Adrian de Boer, Chris McCaw, Margaret Ackman

|Aug 20, 2024
Reappraisal of autologous stem cell transplantation for transformed indolent lymphoma in the bendamustine era.

Colin Stewart, Carolyn Owen, Mona Shafey

Pageof 3

Frequent Collaborators

2 joint publications

Ryan J Stubbins

2 joint publications

Raymond Lai

2 joint publications

Douglas Stewart

2 joint publications

Robert Puckrin